Teva Pharmaceutical Industries Limited v Bayer Intellectual Property GmbH
HPPatents and registered designs
22 documents · supplied by the court
- Division
- Patents Court
- Track
- Part 7 Claim
- Filed
- 7 Nov 2022
- Last updated
- 28 May 2025last year
- Parties
- 8
- Documents
- 22£403.20 for the full file
Parties · 8
Claimant1
- Teva Pharmaceutical Industries LimitedCH ↗Bristows LLP
Part 20 Claimant3
- Bayer Intellectual Property GmbHAllen and Overy LLP
- Bayer AGAllen and Overy LLP
- Bayer PlcCH ↗Allen and Overy LLP
Defendant2
- Bayer Intellectual Property GmbHLitigant in person
- Bayer Intellectual Property GmbHAllen and Overy LLP
Part 20 Defendant2
- Teva Pharmaceutical Industries LimitedCH ↗—
- Teva UK LimitedCH ↗Bristows LLP
Docket · 22
Full file £403.20Filing - Defence
23 May 2025
Defence #
Filing - Amended Defence and Counterclaim
3 Apr 2024
Re-Re-Amended Defence and Counterclaim#
Filing - Amended Claim Form
3 Apr 2024
Amended Claim Form#
Filing - Amended Particulars of Claim
6 Oct 2023
Amended Particulars of Claim#
Filing - Amended Defence & Reply to Counterclaim
22 Sept 2023
Amended Defence & Reply to Counterclaim#
Filing - Amended Defence and Counterclaim
1 Sept 2023
Amended Defence and Counterclaim#
Filing - Amended Reply
1 Sept 2023
Amended Reply#
Filing - Amended Particulars of Claim
7 Aug 2023
Amended Particulars of Claim#
Filing - Amended Reply
7 Aug 2023
Amended Reply#
Filing - Response to Request for Further Information
6 Jul 2023
Response to Request for Further Information#
Order by Judge - Order
23 Jun 2023
sealed EOT order sent to parties#
Filing - Amended Reply
14 Jun 2023
Amended Reply and Defence to Counterclaim. Amended Reply made pursuant to the Order of Meade J dated 2 May 2023. We have sought the Defendant's consent to Amend the Defence to Counterclaim (as set out in the enclosed document) pursuant to CPR 17.1...
Filing - Amended Defence and Counterclaim
31 May 2023
Amended Defence and Counterclaim (#)
Order by Judge - Order
12 May 2023
sealed order sent to parties #
Filing - Response to Request for Further Information
2 Mar 2023
Response to Request for Further Information(#)
Filing - Reply
9 Feb 2023
Reply#
Filing - Response to Request for Further Information
9 Feb 2023
Response to Request for Further Information#
Filing - Reply and Defence to Counterclaim
19 Jan 2023
Reply and Defence to Counterclaim#
Filing - Part 20 Claim Form
8 Dec 2022
Part 20 Claim Form#
Filing - Defence & Counterclaim
8 Dec 2022
Defence & Counterclaim#
Filing - Particulars of Infringement
8 Dec 2022
Particulars of Infringement#
Filing - Claim Form (Part 7)
7 Nov 2022
Claim Form (Part 7) +PoC#
Cross-references
No related case numbers recorded.
Same firms appear in
- HP-2026-000022
Stada Arzneimittel AG and another v Novartis AG
4 Jun 2026
- IP-2026-000058
MMC Holding International Ltd v Somerset Craft Limited
5 May 2026
- HP-2026-000015
Nxera Pharma UK Limited v OMass Therapeutics Limited
23 Apr 2026
- HT-2026-000136
Cityfibre Limited v Lanes Group Limited
23 Apr 2026
- HP-2026-000009
GC Aesthetics Holdings (Brazil) Limited v Establishment Labs S.A.
13 Feb 2026
- HP-2026-000007
Janssen-Cilag Limited v The United States of America, as represented by the Secretary, Department of Health and Human Services
5 Feb 2026
- HP-2026-000006
Throughputer, Inc v Google Cloud EMEA Limited and another
21 Jan 2026
- HP-2025-000058
Teva Pharmaceutical Industries Limited and another v Novartis AG
19 Dec 2025
Record
- Alt case number
- —
- CE-File instance ID
- 856750
- First collected
- 26 Aug 2026
- Last collected
- 26 Aug 2026